Pharma Journalist -

BioMatrix SpRx announced the acquisition of Elwyn Pharmacy Group in Garnet Valley, Pennsylvania, 30 miles southwest of Philadelphia. BioMatrix offers comprehensive nationwide…
Read More...

Spark Therapeutics and Pfizer announced they have entered into an amendment to their license agreement for SPK-9001, an investigational gene therapy for hemophilia B. Spark Therapeutics…
Read More...

Cambrex Corporation announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant. The project has seen the installation of two 500…
Read More...

RxCelerate announced it has hired Laura Hamilton as Executive Vice President, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston. "We are bringing…
Read More...

Boehringer Ingelheim and MiNA Therapeutics (“MiNA”) announced that they have signed a collaboration and licensing agreement focused on the development of novel compounds to treat…
Read More...

Neurimmune announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for…
Read More...

Valeant Pharmaceuticals International announced that its affiliate has entered into an agreement to divest the Sprout Pharmaceuticals subsidiary ("Sprout") to a buyer affiliated with…
Read More...

In a small safety trial based on preclinical work by a Stanford researcher, participants receiving blood plasma infusions from young donors showed some evidence of improvement.…
Read More...

Spanish pharmaceutical company Almirall opted for Werum’s PAS-X Manufacturing Execution System to be installed in the German plant in Reinbek near Hamburg. Almirall is the market leader…
Read More...

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare…
Read More...